Skip to main content
logo
Transgene Biotek Limited (BOM:526139)
India flag India · Delayed Price · Currency is INR
3.010
+0.100 (3.44%)
At close: Jul 31, 2026

Transgene Biotek Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
2.112.112.612.350.550.87
Revenue Growth
-18.99%-18.99%10.98%326.32%-36.44%-48.87%
Gross Profit
2.112.112.612.32-0.111.32
Operating Income
-7.43-7.43-12.16-6.98-60.03-103.85
Net Income
-16.53-16.53-6.76-6.56-60.09-104.02
Earnings Per Share
-0.22-0.22-0.09-0.09-0.79-1.37
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
0.610.612.840.080.030.15
Total Debt
171.37171.37145.2140.01131.13120.08
Net Cash (Debt)
-170.76-170.76-142.36-139.93-131.09-119.93
Net Cash Growth
------
Net Cash Per Share
-2.25-2.25-1.88-1.85-1.73-1.58

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-0.11-0.1111.960.0500.98
Capital Expenditures
---17--0.02-
Free Cash Flow
-0.11-0.11-5.040.05-0.010.98
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
100.00%100.00%100.00%98.72%-20.33%152.09%
Operating Margin
-351.61%-351.61%-466.40%-297.32%-10894.01%-11979.30%
Pretax Margin
-782.62%-782.62%-259.34%-279.05%-10904.90%-11998.40%
Profit Margin
-782.62%-782.62%-259.34%-279.06%-10904.90%-11998.40%
FCF Margin
-5.35%-5.35%-193.21%1.96%-2.36%112.81%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
P/FCF Ratio
---13408.00-279.68
PS Ratio
107.9971.0397.37262.57342.41315.51